Analyst Research

Report Title Price
Provider : Reuters Investment Profile
Provider : Wright Reports
Provider : ValuEngine, Inc.
Provider : GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

CTD Holdings Inc reports progress in Orphan Drug Development

Friday, 15 Aug 2014 08:00am EDT 

CTD Holdings Inc:Reported continued progress on its orphan drug development in Q2 filing with Securities and Exchange Commission.Validation of manufacturing process for Trappsol Cycloâ„¢ product is proceeding as expected, and company plans to file its Drug Master File with FDA in the Q3. 

Company Quote

29 Sep 2015